Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:28:21.964Z.
Calculation as of: 2026-10-06T20:28:21.964Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 97452f2638ad5d60f1716ef7360feea6a822b872a50cf44a9ba771f9e60b5836
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Twist Bioscience Corporation
Market Cap
$10.40B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.31B
Operating Cash Flow Yield
8.83%
TTM Avg
6.86%
3Y Avg
5.22%
5Y Avg
4.52%
Market Cap
$10.24B
Operating Cash Flow Yield
1.24%
TTM Avg
3.60%
3Y Avg
3.15%
5Y Avg
3.15%
Market Cap
$10.19B
Operating Cash Flow Yield
3.58%
TTM Avg
3.71%
3Y Avg
4.53%
5Y Avg
6.94%
Market Cap
$10.15B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.13B
Operating Cash Flow Yield
7.46%
TTM Avg
5.81%
3Y Avg
4.85%
5Y Avg
4.30%
Market Cap
$10.72B
Operating Cash Flow Yield
16.79%
TTM Avg
16.24%
3Y Avg
14.28%
5Y Avg
12.88%
Market Cap
$10.03B
Operating Cash Flow Yield
6.07%
TTM Avg
5.15%
3Y Avg
4.87%
5Y Avg
5.29%
Market Cap
$10.87B
Operating Cash Flow Yield
7.89%
TTM Avg
7.76%
3Y Avg
4.61%
5Y Avg
3.23%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.40B | N/A | N/A | N/A | N/A |
| Globus Medical, Inc. (GMED)vs › | $10.31B | 8.83% | 6.86% | 5.22% | 4.52% |
| 10x Genomics, Inc. (TXG)vs › | $10.24B | 1.24% | 3.60% | 3.15% | 3.15% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | 3.58% | 3.71% | 4.53% | 6.94% |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | N/A | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.13B | 7.46% | 5.81% | 4.85% | 4.30% |
| Universal Health Services, Inc. (UHS)vs › | $10.72B | 16.79% | 16.24% | 14.28% | 12.88% |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | 6.07% | 5.15% | 4.87% | 5.29% |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 7.89% | 7.76% | 4.61% | 3.23% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | 4.96% | 6.17% | 5.41% | 4.44% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
